Chroma Therapeutics' Series B Round

Chroma Therapeutics raised a round of funding on June 14, 2004.

Chroma Therapeutics is a biotechnology company founded to exploit the potential of chromatin biology for cancer drug discovery. Chroma is focused on the identification of anti-cancer agents that combi…

Articles about Chroma Therapeutics' Series B Round: